skip to content

Department of Chemical Engineering and Biotechnology

Dr Geraldine Rodgers

It is with great sadness that we record the death of Dr Geraldine Rodgers, who was associated with the Institute of Biotechnology for over twenty years, most recently as a lecturer on the Bioscience Enterprise programme and in her finance professional capacity. Geraldine joined the University from industry in 1994, initially as Business Manager at the Institute and she concluded her career as Head of Cambridge Enterprise Seed Funds, where she had responsibility for managing an equity portfolio comprising almost 70 companies and spanning all technology sectors. She is acknowledged as a key figure in the founding of many successful life science and other technology companies, including Horizon Discovery, Genapta, Sentinel Oncology and BlueGnome.

In 2004 Geraldine was seconded back to the institute to run the Bioscience Enterprise postgraduate life science business programme, a role in which her expertise in technology commercialisation was invaluable. In a relatively short period Geraldine reshaped the syllabus and strengthened the teaching team through introductions to her network of experts in business and life sciences, laying the foundation of the course as it is provided today.   In her investment capacity Geraldine continued until her retirement to actively engage with Institute spinouts and she remained a close mentor to both staff of the Bioscience Enterprise programme and students undertaking the internship component of the course. The department is grateful for the many messages of condolences received from her past students and joins them in mourning a wonderful colleague and friend.  Without Geraldine much of the success attributed to the Institute would not have been accomplished and we are greatly indebted to her.

Further information

Latest news

Dr Sam Stranks awarded Philip Leverhulme Prize in Physics

18 October 2021

Dr Sam Stranks, who leads our Optoelectronics and Device Spectroscopy Group, has been awarded the 2021 Philip Leverhulme Prize in Physics...

Multi-million-pound centre at the heart of the digital chemistry revolution appoints UK experts to new advisory board

27 September 2021

The Innovation Centre in Digital Molecular Technologies, a multi-million-pound project based at the University of Cambridge, has appointed an External Advisory Board of leading UK experts that will align the centre with both national interests and local priorities in the digital chemistry sector.

Cambridge leads multidisciplinary team in development of a simulator to accelerate the path to net zero flight

27 August 2021

Researchers from CEB will play a key role in the Aviation Impact Accelerator, an international group of experts in aerospace, economics, policy, and climate science, who are developing an interactive evidence-based simulator that explores scenarios for achieving net zero flight.